| Literature DB >> 32270448 |
Naoko Takeda1,2, Shin-Ichi Araki3,4, Masami Chin-Kanasaki3,4, Norihisa Osawa3, Kazunobu Sawai3, Kousuke Yamahara3, Mako Yasuda-Yamahara3, Shinji Kume3, Yukihiro Fujita3, Hiroshi Maegawa3.
Abstract
A 43-year-old male patient on maintenance hemodialysis had an enhanced computed tomography scan examination with iohexol for the first time 10 min before regular hemodialysis therapy. At the start of hemodialysis, no symptoms were observed, and the platelet count was 148,000/μl. Approximately 1 h after starting hemodialysis, dyspnea and chest discomfort appeared. Since oxygen saturation of the peripheral artery decreased to 87%, oxygen administration was immediately started while continuing hemodialysis therapy. Furthermore, gingival hemorrhage was observed, and the platelet count decreased to 5000/μl. We were carefully monitoring his conditions while continuing hemodialysis and oxygen administration, but no further deterioration was observed. Thereafter, these symptoms and severe thrombocytopenia gradually improved without additional treatment. At the end of hemodialysis, these symptoms completely disappeared. As well, the platelet count recovered to 35,000/μl at the end of hemodialysis and increased to 92,000/μl the next morning. From the clinical course, we diagnosed with contrast medium-induced thrombocytopenia. Acute thrombocytopenia is a rare complication induced by the contrast medium. Until now, 16 cases on contrast medium-induced thrombocytopenia have been reported. Our case spontaneously recovered from severe thrombocytopenia relatively earlier than previous reports. Our patient started hemodialysis therapy 10 min after an enhanced computed tomography examination. Early removal of contrast medium by hemodialysis might be associated with early improvement. We should acknowledge that contrast media have potential to induce severe thrombocytopenia, even in patients on maintenance hemodialysis.Entities:
Keywords: Adverse effect; Contrast medium; Hemodialysis; Iohexol; Thrombocytopenia
Year: 2020 PMID: 32270448 PMCID: PMC7320079 DOI: 10.1007/s13730-020-00468-8
Source DB: PubMed Journal: CEN Case Rep ISSN: 2192-4449